Andrew Ciupek, PhD, is Associate Director of Clinical Research at GO₂ Foundation for Lung Cancer. Originally a translational cancer researcher, Andrew transitioned to patient-advocacy to have increased impact on driving patient-centered research.

At GO₂ Foundation, Andrew leads implementation of patient-centric research both with external collaborators and within the Foundation’s Care Continuum Centers of Excellence (CCCOE), a network of community and academic clinical centers focused on lung cancer early detection and treatment. He also serves as a navigator for the Foundation’s treatment and clinical trial navigation program, called LungMATCH, directly working with lung cancer patients and their caregivers to help them understand and access appropriate care options, empowering them to take an informed, active role in medical decisions.

As a research scientist Andrew studied mechanisms of resistance to cancer therapies as well as novel therapeutic targets. He has worked at several institutions, including Baylor College of Medicine, Medical University of South Carolina, and the University of Maryland’s Greenebaum Cancer Center.

Andrew received a PhD in Translational Biology and Molecular Medicine from Baylor College of Medicine and a BS in Biochemistry from the University of Maryland Baltimore County.